|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002006,
umls-concept:C0010181,
umls-concept:C0018801,
umls-concept:C0030705,
umls-concept:C0155626,
umls-concept:C0332206,
umls-concept:C0449255,
umls-concept:C0936012,
umls-concept:C0961485,
umls-concept:C1556084,
umls-concept:C2603343
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2008-12-1
|
|
pubmed:abstractText |
The Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) randomized clinical trial demonstrated the efficacy of eplerenone, a new aldosterone antagonist diuretic, with standard treatment versus standard treatment alone in the reduction of cardiovascular mortality and cardiovascular-related hospital readmissions for patients with heart failure after an acute myocardial infarction.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1875-2136
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
101
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
515-21
|
|
pubmed:dateRevised |
2011-4-25
|
|
pubmed:meshHeading |
pubmed-meshheading:19041835-Aldosterone Antagonists,
pubmed-meshheading:19041835-Cost-Benefit Analysis,
pubmed-meshheading:19041835-Drug Costs,
pubmed-meshheading:19041835-Drug Therapy, Combination,
pubmed-meshheading:19041835-Health Care Costs,
pubmed-meshheading:19041835-Heart Failure,
pubmed-meshheading:19041835-Hospitalization,
pubmed-meshheading:19041835-Humans,
pubmed-meshheading:19041835-Myocardial Infarction,
pubmed-meshheading:19041835-Proportional Hazards Models,
pubmed-meshheading:19041835-Recurrence,
pubmed-meshheading:19041835-Risk Assessment,
pubmed-meshheading:19041835-Secondary Prevention,
pubmed-meshheading:19041835-Spironolactone,
pubmed-meshheading:19041835-Stochastic Processes,
pubmed-meshheading:19041835-Time Factors,
pubmed-meshheading:19041835-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Cost-effectiveness analysis of aldosterone blockade with eplerenone in patients with heart failure after acute myocardial infarction in the French context: the EPHESUS study.
|
|
pubmed:affiliation |
Health Economics, ESSEC, avenue Bernard-Hirsch, BP 50105, 95021 Cergy-Pontoise cedex, France. pouvourville@essec.fr
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial
|
